Tejnaksh Healthcare Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals

Quality Assessment: Weak Fundamentals Persist

Tejnaksh Healthcare’s quality metrics continue to signal caution. The company has exhibited a negative compound annual growth rate (CAGR) of -1.19% in net sales over the past five years, indicating stagnation and lack of growth momentum. Return on Equity (ROE) averaged 9.52% historically, which is modest and suggests limited profitability relative to shareholder funds. More recently, the ROE has declined to 6.3%, underscoring deteriorating efficiency in generating returns.

Quarterly financial results for Q2 FY25-26 were flat, with operating cash flow at a low ₹0.38 crore, reflecting constrained liquidity and operational challenges. Profitability has also been under pressure, with profits falling by 25.7% over the last year. These factors collectively maintain a weak fundamental profile, justifying the company’s low Mojo Grade of Sell despite the upgrade from Strong Sell.

Valuation: Attractive but Reflective of Risks

Despite fundamental weaknesses, Tejnaksh Healthcare’s valuation metrics present a relatively attractive picture. The stock trades at a price-to-book (P/B) ratio of 1.2, which is below the average historical valuations of its healthcare services peers. This discount suggests the market is pricing in the company’s challenges, offering a potential value opportunity for investors willing to tolerate risk.

However, the stock’s market capitalisation grade remains modest at 4, reflecting its micro-cap status and limited liquidity. The current share price of ₹15.83 is closer to its 52-week low of ₹14.01 than the high of ₹29.50, indicating significant downside experienced over the past year. This valuation context is critical for investors weighing the risk-reward balance.

Financial Trend: Flat to Negative Performance

Financial trends for Tejnaksh Healthcare remain subdued. The company’s stock has underperformed the benchmark indices significantly over multiple time horizons. Over the last one year, the stock returned -35.36%, compared to a positive 7.28% return for the Sensex. Over three and five years, the underperformance is even more pronounced, with the stock delivering -71.78% and -44.50% respectively, while the Sensex gained 40.21% and 79.16% over the same periods.

Year-to-date, however, the stock has posted a modest gain of 5.60%, outperforming the Sensex’s 0.64% return. This recent uptick is a positive sign but remains insufficient to offset the longer-term negative trend. The company’s flat quarterly results and weak cash flow generation continue to weigh on investor sentiment.

Technical Analysis: Key Driver of Upgrade

The primary catalyst for the upgrade from Strong Sell to Sell is the improvement in technical indicators. The technical grade shifted from bearish to mildly bearish, signalling a tentative recovery in market sentiment. Weekly MACD remains bearish, but the monthly MACD has turned mildly bullish, suggesting a potential medium-term positive momentum.

Relative Strength Index (RSI) on a weekly basis is bullish, indicating improving buying interest, although the monthly RSI shows no clear signal. Bollinger Bands remain mildly bearish on both weekly and monthly charts, reflecting ongoing volatility and uncertainty. Daily moving averages continue to be bearish, highlighting short-term resistance.

Other technical indicators such as the KST (Know Sure Thing) remain bearish on both weekly and monthly timeframes, while Dow Theory shows a mildly bullish trend weekly but no clear monthly trend. The stock’s price action today reflects this mixed technical picture, with a day change of +2.59%, a high of ₹15.90 and a low of ₹15.13, closing at ₹15.83.

Comparative Performance and Market Position

Tejnaksh Healthcare operates within the hospital and healthcare services industry, a sector that has seen mixed performance amid evolving healthcare demands and regulatory changes. The company’s market cap grade of 4 reflects its micro-cap status, which often entails higher volatility and lower analyst coverage compared to larger peers.

Majority ownership remains with promoters, which can be a double-edged sword: while it ensures control and strategic continuity, it may also limit liquidity and broader institutional participation. The stock’s long-term returns have lagged significantly behind the broader market, with a 10-year return of 255.21% compared to the Sensex’s 227.83%, but this is largely attributable to earlier periods of outperformance before recent declines.

Investment Outlook and Conclusion

While the upgrade to Sell from Strong Sell reflects a technical improvement and a slightly less negative market outlook, Tejnaksh Healthcare Ltd remains a cautious proposition for investors. The company’s weak financial trends, flat recent results, and modest profitability metrics weigh heavily against the stock. However, its attractive valuation and improving technical signals may offer a limited entry point for risk-tolerant investors seeking value in the healthcare services sector.

Investors should closely monitor upcoming quarterly results and any shifts in operational performance, as well as broader sector dynamics. The stock’s relative underperformance against benchmarks and peers suggests that a turnaround is not yet assured, and the Sell rating reflects a balanced view of risk and opportunity.

Summary of Ratings and Scores

As of 2 January 2026, Tejnaksh Healthcare Ltd holds a Mojo Score of 31.0 with a Mojo Grade of Sell, upgraded from Strong Sell. The market cap grade stands at 4. Technical indicators have improved from bearish to mildly bearish, with weekly RSI bullish and monthly MACD mildly bullish. Fundamental quality remains weak with negative sales growth and low ROE. Valuation is attractive with a P/B of 1.2, but financial trends remain flat to negative.

Investors should weigh these factors carefully when considering exposure to this micro-cap healthcare services stock.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Today